Severe Babesia microti infection in an American immunocompetent patient diagnosed in Spain.

[1]  D. Boulware,et al.  Severe Babesiosis in Immunocompetent Man, Spain, 2011 , 2018 .

[2]  P. Krause,et al.  Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both? , 2016, Journal of clinical apheresis.

[3]  N. Dunbar,et al.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue , 2016, Journal of clinical apheresis.

[4]  N. Dunbar,et al.  Introduction to Special Issue: Clinical Applications of Therapeutic Apheresis: An Evidence Based Approach. 7th Edition , 2016 .

[5]  N. Dunbar,et al.  临床实践中治疗性单采术应用指南——基于美国血浆置换学会编写委员会的循证策略：第七版 , 2016 .

[6]  D. Luque,et al.  Severe Babesiosis in Immunocompetent Man, Spain, 2011 , 2014, Emerging infectious diseases.

[7]  J. Gray,et al.  Human Babesiosis in Europe: what clinicians need to know , 2013, Infection.

[8]  Peter J. Krause,et al.  Human babesiosis. , 2008, Infectious disease clinics of North America.

[9]  M. Kiehntopf,et al.  First confirmed autochthonous case of human Babesia microti infection in Europe , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  V. do Rosário,et al.  A fatal case of human babesiosis in Portugal: molecular and phylogenetic analysis , 2003, Tropical medicine & international health : TM & IH.

[11]  P. Conrad,et al.  Human babesiosis: an emerging tick-borne disease. , 2000, International journal for parasitology.

[12]  D. Persing,et al.  Babesiosis: new insights from phylogenetic analysis. , 1995, Infectious agents and disease.